Type II Endometrial Cancer Overexpresses NILCO: A Preliminary Evaluation.
Daley-Brown D, Oprea-Iles G, Vann KT, Lanier V, Lee R, Candelaria PV, Quarshie A, Pattillo R, Gonzalez-Perez RR. Type II Endometrial Cancer Overexpresses NILCO: A Preliminary Evaluation. Dis Markers. 2017; 2017:8248175.